Text Registration
Copyright Title
Development of Glucose Responsive Insulin Therapeutics
Status
Published
on 8 Apr 2021
Year of Creation
2019
Copyright Claimant
Jin Hwan Kim
Registration Number
TX0008952816
on 8 Apr 2021Copyright Summary
The U.S. Copyright record (Registration Number: TX0008952816) dated 8 Apr 2021, pertains to an electronic file (eService) titled "Development of Glucose Responsive Insulin Therapeutics" created in 2019. The copyright holder is Jin Hwan Kim, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Jin Hwan Kim.
Application Details
Registration Number
TX0008952816
Registration Date
4/8/2021
Year of Creation
2019
Agency Marc Code
DLC-CO
Record Status
New
Physical Description
Electronic file (eService)
First Publication Nation
United States
Notes
Rights Note: Mark Dill, ProQuest, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600, disspub@proquest.com
Statements
Application Title Statement: Development of Glucose Responsive Insulin Therapeutics
Author Statement: Jin Hwan Kim Citizenship: not known Authorship: text
© 2023 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.